scholarly article | Q13442814 |
P356 | DOI | 10.1158/1078-0432.CCR-11-2863 |
P698 | PubMed publication ID | 22452940 |
P50 | author | Oluf Dimitri Røe | Q5994996 |
P2093 | author name string | Yan Zhou | |
Gang Li | |||
Jianbing Zhang | |||
Song He | |||
Shouyu Wang | |||
Jianwei Zhou | |||
Jingjing Ding | |||
Jin Bai | |||
Fulin Qiang | |||
Yongfei Tan | |||
Yansu Chen | |||
Xuming Wu | |||
Aiping Li | |||
Zhenghua Gong | |||
Jinyan Zeng | |||
P2860 | cites work | Sealing of chromosomal DNA nicks during nucleotide excision repair requires XRCC1 and DNA ligase III alpha in a cell-cycle-specific manner | Q34654453 |
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 2987-2996 | |
P577 | publication date | 2012-03-27 | |
P1433 | published in | Clinical Cancer Research | Q332253 |
P1476 | title | Prognostic and predictive role of JWA and XRCC1 expressions in gastric cancer | |
P478 | volume | 18 |
Q35742296 | 3,3'-diindolylmethane potentiates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of gastric cancer cells |
Q50063562 | A prognosis and impact factor analysis of DC-CIK cell therapy for patients with hepatocellular carcinoma undergoing postoperative TACE. |
Q64080331 | Adrenergic modulation of AMPK‑dependent autophagy by chronic stress enhances cell proliferation and survival in gastric cancer |
Q58588431 | Associations between three XRCC1 polymorphisms and hepatocellular carcinoma risk: A meta-analysis of case-control studies |
Q89558432 | CHIP-mediated ubiquitination of Galectin-1 predicts colorectal cancer prognosis |
Q35476632 | Cells deficient in base-excision repair reveal cancer hallmarks originating from adjustments to genetic instability |
Q51281400 | DNA base excision repair proteins APE-1 and XRCC-1 are overexpressed in oral tongue squamous cell carcinoma. |
Q45983012 | Decreased expression of DNA repair genes (XRCC1, ERCC1, ERCC2, and ERCC4) in squamous intraepithelial lesion and invasive squamous cell carcinoma of the cervix. |
Q44101885 | Deregulation of base excision repair gene expression and enhanced proliferation in head and neck squamous cell carcinoma |
Q39241544 | Downregulation of JWA promotes tumor invasion and predicts poor prognosis in human hepatocellular carcinoma |
Q35687460 | EGCG regulates the cross-talk between JWA and topoisomerase IIα in non-small-cell lung cancer (NSCLC) cells |
Q47104929 | Effect of AICAR and 5-Fluorouracil on X-ray Repair, Cross-Complementing Group 1 Expression, and Consequent Cytotoxicity Regulation in Human HCT-116 Colorectal Cancer Cells |
Q35618177 | Effects of JWA, XRCC1 and BRCA1 mRNA expression on molecular staging for personalized therapy in patients with advanced esophageal squamous cell carcinoma |
Q37349280 | Excerpts from the 1st international NTNU symposium on current and future clinical biomarkers of cancer: innovation and implementation, June 16th and 17th 2016, Trondheim, Norway |
Q89603057 | HIPK2 suppresses tumor growth and progression of hepatocellular carcinoma through promoting the degradation of HIF-1α |
Q38471484 | Hidden treasures in "ancient" microarrays: gene-expression portrays biology and potential resistance pathways of major lung cancer subtypes and normal tissue |
Q43640344 | High FAK combined with low JWA expression: clinical prognostic and predictive role for adjuvant fluorouracil-leucovorin-oxaliplatin treatment in resectable gastric cancer patients |
Q98159109 | JP1 suppresses proliferation and metastasis of melanoma through MEK1/2 mediated NEDD4L-SP1-Integrin αvβ3 signaling |
Q54937036 | JWA deficiency induces malignant transformation of murine embryonic fibroblast cells. |
Q37687713 | JWA down-regulates HER2 expression via c-Cbl and induces lapatinib resistance in human gastric cancer cells |
Q37392861 | JWA loss promotes cell migration and cytoskeletal rearrangement by affecting HER2 expression and identifies a high-risk subgroup of HER2-positive gastric carcinoma patients |
Q38985247 | JWA regulates human esophageal squamous cell carcinoma and human esophageal cells through different mitogen-activated protein kinase signaling pathways |
Q36291991 | JWA reverses cisplatin resistance via the CK2-XRCC1 pathway in human gastric cancer cells |
Q45354167 | JWA suppresses tumor angiogenesis via Sp1-activated matrix metalloproteinase-2 and its prognostic significance in human gastric cancer |
Q44640223 | Loss expression of PHLPP1 correlates with lymph node metastasis and exhibits a poor prognosis in patients with gastric cancer |
Q39035676 | Loss of XRCC1 confers a metastatic phenotype to melanoma cells and is associated with poor survival in patients with melanoma. |
Q39205410 | MDM2 is a useful prognostic biomarker for resectable gastric cancer |
Q52655540 | MPO promoter polymorphism rs2333227 enhances malignant phenotypes of colorectal cancer by altering the binding affinity of AP-2α. |
Q35375517 | Methyl-methanesulfonate sensitivity 19 expression is associated with metastasis and chemoradiotherapy response in esophageal cancer |
Q55078362 | Persistent DNA strand breaks induce a CAF-like phenotype in normal fibroblasts. |
Q35919215 | PinX1 is up-regulated and associated with poor patients' survival in gliomas |
Q40979612 | Predictive and prognostic values of ERCC1 and XRCC1 in biliary tract cancers. |
Q43452895 | Predictive value of ERCC1, ERCC2, and XRCC1 overexpression for stage III colorectal cancer patients receiving FOLFOX-4 adjuvant chemotherapy |
Q90320075 | Probiotics Ameliorate Colon Epithelial Injury Induced by Ambient Ultrafine Particles Exposure |
Q33715750 | Prognostic Biomarker Identification Through Integrating the Gene Signatures of Hepatocellular Carcinoma Properties |
Q33598872 | Prognostic and predictive role of COX-2, XRCC1 and RASSF1 expression in patients with esophageal squamous cell carcinoma receiving radiotherapy |
Q37104601 | Prognostic significance of X-ray cross-complementing gene 1 expression in gastric cancer |
Q50947717 | Relationship Between Expression of Proteins ERCC1, ERCC2, and XRCC1 and Clinical Outcomes in Patients with Rectal Cancer Treated with FOLFOX-Based Preoperative Chemoradiotherapy. |
Q57453388 | Relationship between expression of XRCC1 and tumor proliferation, migration, invasion, and angiogenesis in glioma |
Q38787554 | SOX2 inhibits metastasis in gastric cancer |
Q38375695 | Synergistic efficacy of Cullin1 and MMP-2 expressions in diagnosis and prognosis of colorectal cancer |
Q34533669 | Synergistic role between p53 and JWA: prognostic and predictive biomarkers in gastric cancer |
Q91779675 | TIMP-2 inhibits metastasis and predicts prognosis of colorectal cancer via regulating MMP-9 |
Q37620658 | TXNL1-XRCC1 pathway regulates cisplatin-induced cell death and contributes to resistance in human gastric cancer |
Q39078294 | The opposite prognostic significance of nuclear and cytoplasmic p21 expression in resectable gastric cancer patients |
Q34976982 | The prognostic value of SOX2 expression in non-small cell lung cancer: a meta-analysis |
Q95277472 | XRCC1 Is a Promising Predictive Biomarker and Facilitates Chemo-Resistance in Gallbladder Cancer |
Q47097874 | XRCC1 mediated the development of cervival cancer through a novel Sp1/Krox-20 swich |
Q47175563 | XRCC1 serves as a potential prognostic indicator for clear cell renal cell carcinoma and inhibits its invasion and metastasis through suppressing MMP-2 and MMP-9. |
Search more.